Wegovy tablets and injections contain semaglutide but deliver it differently [1]. If you are comparing pill and injection prices, confirm which drug and formulation each price covers. The number of milligrams cannot establish whether two products are interchangeable.
What the US label says
The Wegovy tablet maintenance dose is 25 mg daily [1]. The usual recommended injection maintenance dose for adult weight management is 2.4 mg weekly. The label also has other injection dose options for some adults.
Wegovy tablets include an ingredient called SNAC that helps the body absorb semaglutide [1]. Estimated absorption is about 1% to 2% for the tablet, compared with about 89% for the injection. Formulation matters when reading the evidence on compounded semaglutide, since the Wegovy results apply to the product studied. A labeled dose alone does not establish equivalent absorption.
What the weight-loss trials found
In OASIS 4, the 25 mg tablet group lost an estimated 13.6% at week 64 [2]. The placebo group lost 2.2%. The estimated difference was 11.4 percentage points, with a 95% confidence interval of 9.0 to 13.9 points.
In STEP 1, the 2.4 mg injection group lost an estimated 14.9% at week 68 [3]. The placebo group lost 2.4%. An earlier oral trial, OASIS 1, studied a 50 mg tablet and reported a 15.1% loss at week 68 [4]. The 50 mg dose was used in that trial. The US label specifies 25 mg for Wegovy tablet maintenance.
Each trial compared semaglutide with placebo in a different group. The study averages cannot show that the tablet and injection produce the same result in the same patients.